Alan W. Dunton, MD, Chief Medical Advisor of Recce Pharmaceuticals, added, “We are thrilled to see such robust clinical results from our Phase II trial. These results demonstrate the potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback